Related Experiment Video
Updated: May 10, 2026

Removal of Trace Elements by Cupric Oxide Nanoparticles from Uranium In Situ Recovery Bleed Water and Its Effect on Cell Viability
Published on: June 21, 2015
Blood Arsenic and Cadmium Concentrations in End-Stage Renal Disease Patients who were on Maintenance Haemodialysis
Subha Palaneeswari M1, P M Abraham Sam Rajan, Santhi Silambanan
1Assistant Professor, Department of Biochemistry, Sree Balaji Medical College and Hospital , Chrompet, Chennai-600 044, India .
Insights
Blood arsenic and cadmium levels are elevated in end-stage renal disease (ESRD) patients undergoing maintenance hemodialysis (MHD). These levels increase with the duration of MHD, suggesting a link to chronic kidney disease progression.
Area of Science:
- Nephrology
- Environmental Health
- Toxicology
Background:
- Rising burden of chronic diseases like hypertension and diabetes in India.
- 25-40% of these patients develop chronic kidney disease (CKD), often requiring renal replacement therapy.
- Haemodialysis is a common treatment for end-stage renal disease (ESRD).
Purpose of the Study:
- To investigate blood arsenic and cadmium levels in ESRD patients on maintenance haemodialysis (MHD).
- To determine if there is a relationship between these element concentrations and the duration of MHD.
Main Methods:
- Blood samples analyzed from 50 healthy subjects and 50 ESRD patients on MHD.
- Exclusion of participants with a history of smoking or industrial exposure.
Main Results:
- Significantly higher blood arsenic and cadmium concentrations in ESRD patients on MHD compared to healthy controls.
- A positive correlation observed between blood arsenic and cadmium levels and the duration of MHD.
Conclusions:
- Elevated blood arsenic and cadmium in MHD patients suggest potential environmental exposure.
- Prolonged exposure, even at low levels, may contribute to renal damage or CKD progression.
- Further research is warranted to explore the implications of these findings.
Background:
In India, there is a rising burden of chronic diseases like hypertension and diabetes. It has been estimated that 25-40% of these patients are likely to develop chronic kidney disease (CKD), with a significant percentage requiring renal replacement therapy. Haemodialysis is the most common method which is used to treat advanced and permanent kidney failure. Derangements in the metabolism of several toxic and trace elements such as antimony, arsenic cadmium, molybdenum, nickel, and selenium have been reported for several decades in patients with chronically reduced renal functions. Overall, the available literature suggests that the blood levels of some elements such as cadmium, chromium, fluorine, iodine, lead, or vanadium are high in end-stage renal disease (ESRD).
Aim And Objectives:
Our aim was to study the levels of blood arsenic and cadmium in ESRD patients who were on maintenance haemodialysis (MHD), and to study whether there was any relationship between their concentrations and the duration of the MHD.
Methods:
The blood lead levels were determined in 50 healthy subjects with normal renal functions and in 50 patients with ESRD, who were on MHD. None of them had any history of smoking or any industrial exposure.
Results:
The results of the study revealed that the blood arsenic and cadmium concentrations were higher in the ESRD patients who were on MHD than in the healthy adults. The blood arsenic and cadmium concentrations were found to increase with the duration of the MHD.
Conclusion:
The mild increase in the blood arsenic and cadmium concentrations, with an increase in the duration of the MHD in the study population, may be viewed in the wider context, that a prolonged exposure to arsenic and cadmium, even at low levels, may result in renal damage and/or progression of an already existing CKD.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Hemodialysis III: Nursing Management
Chronic Kidney Disease II: Clinical Manifestations
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Hemodialysis II: Procedure and Complications
Chronic Kidney Disease I: Introduction
